Full Text View
Tabular View
No Study Results Posted
Related Studies
A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)
This study has been terminated.
( Please see Detailed Description for termination reason. )
Study NCT00735267   Information provided by Pfizer

First Received on August 12, 2008.   Last Updated on November 9, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Generalized Anxiety Disorder
Additional conditions recognized in this trial
Anxiety Disorders
More general conditions related to this trial
Mental Disorders
Interventions listed in this trial
PD 0332334
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services